Every 10-Q that Silicon Laboratories Inc (SLAB) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SLAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SLAB filings page.
Silicon Laboratories Inc. reported higher sales but continued losses for the quarter ended July 4, 2026 while progressing toward an all-cash acquisition by Texas Instruments. Under the approved merger agreement, each outstanding share will be converted into $231.00 in cash at closing, expected in the first half of 2027, subject to regulatory and other customary conditions.
Quarterly revenues were $228.2 million, up from $192.8 million a year earlier, driven by both Industrial & Commercial and Home & Life products. Gross margin improved to 61.6%, but higher research and development and selling, general and administrative expenses, including merger-related costs, resulted in a quarterly net loss of $10.6 million. For the first half of 2026, the company lost $26.5 million.
Silicon Labs ended the quarter with $397.2 million in cash, cash equivalents and short-term investments and an undrawn $400 million revolving credit facility. Operating cash flow for the first half swung to an outflow of $9.6 million, mainly due to higher inventories and accounts receivable. Inventory days rose to 127, and the company noted ongoing macroeconomic and geopolitical uncertainties alongside significant expected additional merger-related costs.
Silicon Laboratories Inc. reports higher Q1 revenue but remains unprofitable while progressing toward an all-cash sale to Texas Instruments. Revenue for the quarter ended April 4, 2026 rose to $213.5 million from $177.7 million, driven by strong Industrial & Commercial and Home & Life demand. Gross margin improved to 59.5%, and the net loss narrowed to $15.9 million, or $0.48 per share, compared with a $30.5 million loss a year earlier.
Cash, cash equivalents and short-term investments totaled $438.9 million, with positive operating cash flow of $4.9 million and no borrowings on a $400 million revolving credit facility. The company entered into a Merger Agreement under which each share will be converted into the right to receive $231.00 in cash, subject to customary closing conditions, with closing expected in the first half of 2027. Silicon Labs recorded $11.2 million of merger-related costs in the quarter and highlights ongoing macroeconomic and geopolitical risks, as well as regulatory and closing risks related to the proposed transaction.
Silicon Laboratories (SLAB) reported stronger Q3 results as demand recovered. Revenue rose to $205.999 million from $166.395 million, and gross margin improved to 57.8%. Operating loss narrowed to $12.342 million from $29.708 million, and net loss improved to $9.936 million from $28.504 million. Industrial & Commercial revenue reached $117.614 million, while Home & Life delivered $88.385 million.
Year‑to‑date revenue was $576.558 million vs. $418.137 million. Cash, cash equivalents and short‑term investments totaled $439.0 million, with operating cash flow of $87.358 million for the nine‑month period. Inventory declined to $82.190 million (85 DOI) and DSO was 29 days. The company had no borrowings under its $400 million revolver and was in covenant compliance. As of October 28, 2025, 32,852,942 common shares were outstanding. The Norwegian Tax Appeals Board decided in the company’s favor regarding a 2013 tax assessment.